Article thumbnail
Location of Repository

Epithelial to Mesenchymal Transition of a Primary Prostate Cell Line with Switches of Cell Adhesion Modules but without Malignant Transformation

By Xi-Song Ke, Yi Qu, Naomi Goldfinger, Kari Rostad, Randi Hovland, Lars A. Akslen, Varda Rotter, Anne Margrete Øyan and Karl-Henning Kalland
Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2007). A human threedimensional cell line model allows the study of dynamic and reversible epithelialmesenchymal and mesenchymal-epithelial transition that underpins colorectal carcinogenesis. Cells Tissues Organs 185:
  2. (2007). A switch from Ecadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer.
  3. (2006). A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer.
  4. (2004). Adult human mesenchymal stem cell as a target for neoplastic transformation.
  5. (1964). Agar Suspension Culture for the Selective Assay of Cells Transformed by Polyoma Virus.
  6. (2007). An in vitro model of posterior capsular opacity: SPARC and TGF-beta2 minimize epithelial-to-mesenchymal transition in lens epithelium.
  7. (2007). BMP4 induces EMT and Rho GTPase activation in human ovarian cancer cells.
  8. (2007). Cell contactdependent regulation of epithelial-myofibroblast transition via the rho-rho kinase-phospho-myosin pathway.
  9. (1998). Cell-cell communication in carcinogenesis.
  10. (2008). Cell-cell contact interactions conditionally determine suppression and selection of the neoplastic phenotype.
  11. (1974). Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium.
  12. (2005). Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer.
  13. (2007). Comparison of nucleic acid targets prepared from total RNA or poly(A) RNA for DNA oligonucleotide microarray hybridization.
  14. (2006). Complex networks orchestrate epithelialmesenchymal transitions.
  15. (2000). Connexin43 suppresses MFG-E8 while inducing contact growth inhibition of glioma cells.
  16. (2006). Cooperation between snail and LEF-1 transcription factors is essential for TGF-beta1-induced epithelialmesenchymal transition.
  17. (1999). Creation of human tumour cells with defined genetic elements.
  18. (2005). Degrees and kinds of selection in spontaneous neoplastic transformation: an operational analysis.
  19. (2005). DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells.
  20. (2005). Diverse biological effect and Smad signaling of bone morphogenetic protein 7 in prostate tumor cells.
  21. (2003). Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion.
  22. (2004). Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis.
  23. (2007). Epithelial-mesenchymal and mesenchymal-epithelial transitions during cancer progression.
  24. (2008). Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype.
  25. (2002). Epithelial-mesenchymal transitions in tumour progression.
  26. (2004). Epithelial-mesenchymal transitions: twist in development and metastasis.
  27. (2007). Epithelial–mesenchymal and mesenchymal–epithelial transitions in carcinoma progression.
  28. (2005). Expression of Frzb/ secreted Frizzled-related protein 3, a secreted Wnt antagonist, in human androgen-independent prostate cancer PC-3 cells suppresses tumor growth and cellular invasiveness.
  29. (2006). Expression of Snail protein in tumor-stroma interface.
  30. (2006). Genetic aberrations in prostate cancer by microarray analysis.
  31. (1991). Growth factors in development, transformation, and tumorigenesis.
  32. (2006). hTERTimmortalized prostate epithelial and stromal-derived cells: an authentic in vitro model for differentiation and carcinogenesis.
  33. (2006). Hypoxia-inducible factor1alpha induces the epithelial-mesenchymal transition of human prostatecancer cells.
  34. (2000). Identification of a high frequency of chromosomal rearrangements in the centromeric regions of prostate cancer cell lines by sequential giemsa banding and spectral karyotyping.
  35. (2001). Identification of genes involved in epithelial-mesenchymal transition and tumor progression.
  36. (2007). Inducible FGFR-1 activation leads to irreversible prostate adenocarcinoma and an epithelial-to-mesenchymal transition.
  37. (2007). Interplay of distinct growth factors during epithelial-mesenchymal transition of cancer progenitor cells and molecular targeting as novel cancer therapies.
  38. (2001). J-Express: exploring gene expression data using Java.
  39. (2008). Levitzki A
  40. (2008). Loss of singleminded-2s in the mouse mammary gland induces an epithelial-mesenchymal transition associated with up-regulation of slug and matrix metalloprotease
  41. (1997). Malignant transformation of human prostate epithelial cells by N-nitroso-N-methylurea.
  42. (2008). Membrane type 1-matrix metalloproteinase (MT1-MMP) induces epithelial-tomesenchymal transition (EMT) in prostate cancer.
  43. (2007). Mesenchymal to epithelial transition in development and disease.
  44. (2008). Modulation of several waves of gene expression during FGF-1 induced epithelial-mesenchymal transition of carcinoma cells.
  45. (2005). Molecular requirements for epithelialmesenchymal transition during tumor progression.
  46. (1999). N-Cadherin expression in human prostate carcinoma cell lines. An epithelial-mesenchymal transformation mediating adhesion with stromal cells.
  47. (2000). N-Cadherin extracellular repeat 4 mediates epithelial to mesenchymal transition and increased motility.
  48. (1995). Nuclear export of the human immunodeficiency virus type 1 nucleocytoplasmic shuttle protein Rev is mediated by its activation domain and is blocked by transdominant negative mutants.
  49. (1998). Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front.
  50. (2008). p73 poses a barrier to malignant transformation by limiting anchorageindependent growth.
  51. (1997). PCadherin is a basal cell-specific epithelial marker that is not expressed in prostate cancer.
  52. (2006). Phenotypic characterization of telomerase-immortalized primary non-malignant and malignant tumor-derived human prostate epithelial cell lines.
  53. (2007). Pre-EMTing metastasis? Recapitulation of morphogenetic processes in cancer.
  54. (2008). Prostate cell cultures as in vitro models for the study of normal stem cells and cancer stem cells.
  55. (1996). Radiation-induced neoplastic transformation of human prostate epithelial cells.
  56. (2006). Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis.
  57. (2007). Reduced PDEF expression increases invasion and expression of mesenchymal genes in prostate cancer cells.
  58. (2003). Regulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins/occludin by Snail.
  59. (2008). Simultaneously detection of genomic and expression alterations in prostate cancer using cDNA microarray.
  60. (2005). Stepwise neoplastic transformation of a telomerase immortalized fibroblast cell line.
  61. (2003). Sticky business: orchestrating cellular signals at adherens junctions.
  62. (2008). Tetraspanin TM4SF5 mediates loss of contact inhibition through epithelial-mesenchymal transition in human hepatocarcinoma.
  63. (1966). The Difference in Contact Inhibition of Cell Replication between Normal Cells and Cells Transformed by Different Carcinogens.
  64. (2008). The epithelialmesenchymal transition generates cells with properties of stem cells.
  65. (2006). The epithelialmesenchymal transition: new insights in signaling, development, and disease.
  66. (2005). The fallacy of epithelial mesenchymal transition in neoplasia.
  67. (2000). The hallmarks of cancer.
  68. (2007). The role of epithelial-mesenchymal transition in cancer pathology.
  69. (2001). The use of multicolor fluorescence technologies in the characterization of prostate carcinoma cell lines: a comparison of multiplex fluorescence in situ hybridization and spectral karyotyping data.
  70. (2007). The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition.
  71. (1997). The zinc-finger protein slug causes desmosome dissociation, an initial and necessary step for growth factor-induced epithelial-mesenchymal transition.
  72. (1989). Transformation of human neonatal prostate epithelial cells by strontium phosphate transfection with a plasmid containing SV40 early region genes.
  73. (2004). Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis.
  74. (2007). Up-regulation of gastric cancer cell invasion by Twist is accompanied by N-cadherin and fibronectin expression.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.